Skip to content
The Nexus
HEALTHApr 30 · 15:00 UTCTHE GUARDIAN WORLDMattha Busby

Active-duty US soldiers to receive psychedelic drugs for PTSD next year

Active-duty US soldiers with PTSD will undergo MDMA-assisted therapy in 2024 as part of Department of Defense-funded studies. The therapy aims to help soldiers process trauma, with 186 participants expected to take part in multiple sessions.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Department of DefenseorganizationMDMA-assisted therapytopicPTSDtopicactive-duty US soldierspersonwar on drugstopic
Spot something wrong with this article?Report a problem →
Forward this